Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Routine or targeted HIV screening of Indonesian prisoners.

Nelwan EJ, Isa A, Alisjahbana B, Triani N, Djamaris I, Djaja I, Pohan HT, Zwanikken P, van Crevel R, van der Ven A, Meheus A.

Int J Prison Health. 2016;12(1):17-26. doi: 10.1108/IJPH-04-2015-0012.

PMID:
26933989
2.

EFFECT OF HIV PREVENTION AND TREATMENT PROGRAM ON HIV AND HCV TRANSMISSION AND HIV MORTALITY AT AN INDONESIAN NARCOTIC PRISON.

Nelwan EJ, Indrati AK, Isa A, Triani N, Alam NN, Herlan MS, Husen W, Pohan HT, Alisjahbana B, Meheus A, Van Crevel R, van der Ven AJ.

Southeast Asian J Trop Med Public Health. 2015 Sep;46(5):880-91.

PMID:
26863859
3.

Vaccines for sexually transmitted infections: past, present and future.

Fruth U, Broutet N, Deal C, Dodet B, Meheus A.

Vaccine. 2014 Mar 20;32(14):1525-6. doi: 10.1016/j.vaccine.2014.01.051. Epub 2014 Jan 28. No abstract available.

PMID:
24480028
4.

Hepatitis B vaccination policies for student healthcare workers in Europe.

De Schryver A, Claesen B, Meheus A, Hambach R, van Sprundel M, François G.

J Hosp Infect. 2014 Feb;86(2):147-50. doi: 10.1016/j.jhin.2013.11.005. Epub 2013 Dec 1.

PMID:
24360409
5.

Addressing public questioning and concerns about vaccination in South Africa: a guide for healthcare workers.

Burnett RJ, Larson HJ, Moloi MH, Tshatsinde EA, Meheus A, Paterson P, François G.

Vaccine. 2012 Sep 7;30 Suppl 3:C72-8. doi: 10.1016/j.vaccine.2012.03.037. Review.

PMID:
22939026
6.

An update after 16 years of hepatitis B vaccination in South Africa.

Burnett RJ, Kramvis A, Dochez C, Meheus A.

Vaccine. 2012 Sep 7;30 Suppl 3:C45-51. doi: 10.1016/j.vaccine.2012.02.021. Review.

PMID:
22939021
7.

Introducing new vaccines into the South African national immunisation programme - a case study.

Schoub BD, Mphahlele MJ, Ngcobo NJ, Hoosen AA, Meheus A.

Vaccine. 2012 Sep 7;30 Suppl 3:C1-2. doi: 10.1016/j.vaccine.2012.06.094. No abstract available.

PMID:
22939014
8.

Hepatitis B vaccination coverage in healthcare workers in Gauteng Province, South Africa.

Burnett RJ, François G, Mphahlele MJ, Mureithi JG, Africa PN, Satekge MM, Mokonoto DM, Meheus A, van Sprundel M.

Vaccine. 2011 Jun 6;29(25):4293-7. doi: 10.1016/j.vaccine.2011.03.001. Epub 2011 Apr 3.

PMID:
21419165
9.

Evaluation of mid-level management training in immunisation in the African region.

Mutabaruka E, Dochez C, Nshimirimana D, Meheus A.

East Afr J Public Health. 2010 Mar;7(1):37-43.

PMID:
21413570
10.

Occupational risk for human immunodeficiency virus, hepatitis B, and hepatitis C infection in health care workers in a teaching hospital in Indonesia.

Antono SK, Raya RP, Irda Sari SY, Afriandi I, Anwar AD, Setiabudi D, Meheus A, De Schryver A, Pinxten L.

Am J Infect Control. 2010 Nov;38(9):757-8. doi: 10.1016/j.ajic.2010.03.016. No abstract available.

PMID:
21034982
11.

Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening.

Nelwan EJ, Van Crevel R, Alisjahbana B, Indrati AK, Dwiyana RF, Nuralam N, Pohan HT, Jaya I, Meheus A, Van Der Ven A.

Trop Med Int Health. 2010 Dec;15(12):1491-8. doi: 10.1111/j.1365-3156.2010.02655.x. Epub 2010 Oct 18.

12.

European survey of hepatitis B vaccination policies for healthcare workers.

De Schryver A, Claesen B, Meheus A, van Sprundel M, François G.

Eur J Public Health. 2011 Jun;21(3):338-43. doi: 10.1093/eurpub/ckq122. Epub 2010 Sep 3.

PMID:
20817688
13.

An estimation of the occupational risk of HBV, HCV and HIV infection among Indonesian health-care workers.

Agustian D, Yusnita S, Susanto H, Sukandar H, de Schryver A, Meheus A.

Acta Med Indones. 2009 Jul;41 Suppl 1:33-7.

14.

Infectious diseases in people with intellectual disabilities.

De Schryver AA, Meheus A.

BMJ. 2009 Jan 21;338:b194. doi: 10.1136/bmj.b194. No abstract available.

PMID:
19158170
15.

A trial of the validity of genital smears and cultures with gonococcal vaccine provocation in diagnosing genital gonorrhoea in women.

Renton A, Filatova E, Ison C, Meheus A, Dmitriev G, Akovbian V, Taylor-Robinson D.

Int J STD AIDS. 2009 Jan;20(1):24-9. doi: 10.1258/ijsa.2008.008147.

PMID:
19103889
16.

Performance of direct fluorescent antibody tests for routine diagnosis of Chlamydia trachomatis in Russian sexually transmitted disease clinics.

Renton A, Filatova E, Ison C, Meheus A, Dmitriev G, Akovbian V, Taylor-Robinson D.

Int J STD AIDS. 2008 Dec;19(12):851-5. doi: 10.1258/ijsa.2008.008149.

PMID:
19050218
17.

Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic.

Simani OE, Leroux-Roels G, François G, Burnett RJ, Meheus A, Mphahlele MJ.

Vaccine. 2009 Jan 1;27(1):146-51. doi: 10.1016/j.vaccine.2008.10.004. Epub 2008 Oct 20.

PMID:
18940220
18.

Oral fluid detection of hepatitis B vaccine-induced antibodies can improve vaccination programmes.

Simani OE, François G, Burnett RJ, Meheus A, Basetse HR, Mphahlele MJ.

S Afr Med J. 2008 Aug;98(8):608-9. No abstract available.

PMID:
18928038
19.

Yaws eradication: past efforts and future perspectives.

Asiedu K, Amouzou B, Dhariwal A, Karam M, Lobo D, Patnaik S, Meheus A.

Bull World Health Organ. 2008 Jul;86(7):499-499A. No abstract available.

20.

Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women.

Burnett RJ, Ngobeni JM, François G, Hoosen AA, Leroux-Roels G, Meheus A, Mphahlele MJ.

Int J STD AIDS. 2007 Mar;18(3):152-6.

PMID:
17362544
21.

Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.

Wright TC, Bosch FX, Franco EL, Cuzick J, Schiller JT, Garnett GP, Meheus A.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/251-61. Review.

PMID:
16950014
22.

Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer.

Franco EL, Bosch FX, Cuzick J, Schiller JT, Garnett GP, Meheus A, Wright TC.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/242-9. Review.

PMID:
16950013
23.

Chapter 14: HPV vaccine introduction in industrialized countries.

Wright TC, Van Damme P, Schmitt HJ, Meheus A.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/122-31. Review.

PMID:
16949999
24.

Contact lens-related corneal ulcers requiring hospitalization: a 7-year retrospective study in Belgium.

Verhelst D, Koppen C, Van Looveren J, Meheus A, Tassignon MJ; Belgian Keratitis Study Group.

Acta Ophthalmol Scand. 2006 Aug;84(4):522-6.

25.

Vaccine safety controversies and the future of vaccination programs.

François G, Duclos P, Margolis H, Lavanchy D, Siegrist CA, Meheus A, Lambert PH, Emiroğlu N, Badur S, Van Damme P.

Pediatr Infect Dis J. 2005 Nov;24(11):953-61. Review.

PMID:
16282928
26.

Clinical, epidemiological and cost aspects of contact lens related infectious keratitis in Belgium: results of a seven-year retrospective study.

Verhelst D, Koppen C, Van Looveren J, Meheus A, Tassignon MJ; Belgian Keratitis Study Group.

Bull Soc Belge Ophtalmol. 2005;(297):7-15.

PMID:
16281729
27.

Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.

Fitzsimons D, François G, Hall A, McMahon B, Meheus A, Zanetti A, Duval B, Jilg W, Böcher WO, Lu SN, Akarca U, Lavanchy D, Goldstein S, Banatvala J, Damme PV.

Vaccine. 2005 Jul 14;23(32):4158-66. Epub 2005 Apr 13.

PMID:
15964484
28.

Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation.

Burnett RJ, François G, Kew MC, Leroux-Roels G, Meheus A, Hoosen AA, Mphahlele MJ.

Liver Int. 2005 Apr;25(2):201-13. Review.

PMID:
15780040
29.

Maternal and congenital syphilis programmes: case studies in Bolivia, Kenya and South Africa.

Deperthes BD, Meheus A, O'Reilly K, Broutet N.

Bull World Health Organ. 2004 Jun;82(6):410-6. Review.

30.

Prevention of hepatitis C virus infection.

Kew M, François G, Lavanchy D, Margolis H, Van Damme P, Grob P, Hallauer J, Shouval D, Leroux-Roels G, Meheus A; Viral Hepatitis Prevention Board.

J Viral Hepat. 2004 May;11(3):198-205. Review.

PMID:
15117321
31.

Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe.

Parkes R, Renton A, Meheus A, Laukamm-Josten U.

Int J STD AIDS. 2004 Feb;15(2):73-88. Review. No abstract available.

PMID:
15006068
32.

Hepatitis B surface antigenaemia following vaccination with a combined vaccine against hepatitis A and B.

De Schryver A, De Gendt K, François G, Van Damme P, Meheus A.

J Viral Hepat. 2004 Jan;11(1):88-90.

PMID:
14738563
33.

Chlamydial infection: an accurate model for opportunistic screening in general practice.

Verhoeven V, Avonts D, Meheus A, Goossens H, Ieven M, Chapelle S, Lammens C, Van Royen P.

Sex Transm Infect. 2003 Aug;79(4):313-7. Erratum in: Sex Transm Infect. 2003 Oct;79(5):429.

34.

Performance of the recommendations of a British advisory group for screening for chlamydia in a sample of women in general practice.

Verhoeven V, Avonts D, Meheus A, Ieven M, Goossens H, Van Royen P.

J Med Screen. 2003;10(1):14-5.

PMID:
12790310
35.

First, do not harm: also an issue in NAA assay diagnostics for chlamydial infection.

Verhoeven V, Ieven M, Meheus A, Avonts D, Goossens H.

Sex Transm Infect. 2003 Feb;79(1):76-7. No abstract available.

36.

Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Java, Indonesia.

Ieven M, Van Looveren M, Sudigdoadi S, Rosana Y, Goossens W, Lammens C, Meheus A, Goossens H.

Sex Transm Dis. 2003 Jan;30(1):25-9.

PMID:
12514438
37.

The difficult quest for data on "vanishing" vaccine-preventable infections in Europe: the case of measles in Flanders (Belgium).

Beutels P, Van Damme P, Van Casteren V, Gay NJ, De Schrijver K, Meheus A.

Vaccine. 2002 Oct 4;20(29-30):3551-9.

PMID:
12297401
38.

Strengthening immunization systems and introduction of hepatitis B vaccine in central and eastern Europe and the newly independent states.

FitzSimons D, Van Damme P, Emiroglu N, Godal T, Kane M, Malyavin A, Margolis H, Meheus A.

Vaccine. 2002 Feb 22;20(11-12):1475-9. No abstract available.

PMID:
11858851
39.

The endemic treponematoses.

Antal GM, Lukehart SA, Meheus AZ.

Microbes Infect. 2002 Jan;4(1):83-94. Review.

PMID:
11825779
40.

Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?

François G, Kew M, Van Damme P, Mphahlele MJ, Meheus A.

Vaccine. 2001 Jul 16;19(28-29):3799-815. Review. No abstract available.

PMID:
11427251
41.

Pros and cons of an illicit drug users' registration system by means of judicial data in Flanders (Belgium).

Van Hal G, De Groote K, Van Damme P, Pepermans K, Van Cauwenberghe K, Meheus A.

Public Health. 2001 Jan;115(1):70-7.

PMID:
11402355
42.

Hepatitis B vaccine is not associated with liver problems in US children less than 6 years old.

van Damme P, van Herck K, Meheus A.

Epidemiology. 2000 May;11(3):364; author reply 366. No abstract available.

PMID:
10784262
43.

Artificial nodules of the penis: case report of an Indonesian man.

Djajakusumah TS, Meheus A.

Sex Transm Dis. 2000 Mar;27(3):152-3. No abstract available.

PMID:
10726648
44.

Teenagers' lifestyle and the risk of exposure to hepatitis B virus.

Meheus A.

Vaccine. 2000 Feb 18;18 Suppl 1:S26-9.

PMID:
10683540
45.

Hepatitis B and C in institutions for individuals with intellectual disability.

Vellinga A, Van Damme P, Meheus A.

J Intellect Disabil Res. 1999 Dec;43 ( Pt 6):445-53. Review.

PMID:
10622359
46.

Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates.

Vranckx R, Alisjahbana A, Meheus A.

J Viral Hepat. 1999 Mar;6(2):135-9.

PMID:
10607224
47.

Should we be screening for asymptomatic HSV infections?

Brugha R, Brown D, Meheus A, Renton A.

Sex Transm Infect. 1999 Jun;75(3):142-4. No abstract available.

PMID:
10448387
48.

Cervical dysplasia and HIV type 1 infection in African pregnant women: a cross sectional study, Kigali, Rwanda. The Pregnancy and HIV Study Group (EGE).

Leroy V, Ladner J, De Clercq A, Meheus A, Nyiraziraje M, Karita E, Dabis F.

Sex Transm Infect. 1999 Apr;75(2):103-6.

49.

Multiple sclerosis and hepatitis B vaccine?

Hall A, Kane M, Roure C, Meheus A.

Vaccine. 1999 Jun 4;17(20-21):2473-5. No abstract available.

PMID:
10418891
50.

Hepatitis B vaccination in mentally retarded: effectiveness after 11 years.

Vellinga A, Van Damme P, Weyler JJ, Vranckx R, Meheus A.

Vaccine. 1999 Feb 12;17(6):602-6.

PMID:
10075168

Supplemental Content

Loading ...
Support Center